The new Clinical and Translational Core will promote and facilitate clinical and translational studies in hypertension, kidney disorders, and related cardiovascular diseases. The main functions will be: promotion of translational studies, and establishment of synergies between basic scientists, physician scientists, and population scientist;facilitation of new studies including protocol design, IRB submission, coordination of services needed, subject recruitment, data management design;performance of clinical visits;assistance with management of data and biostatistical support;sample processing and analysis;coordination with the CTC, facilities within Tulane Hospital or MCLNO, IRB;and facilitation of education and training in clinical research. Clinical and translational studies will usually be performed within two well equipped facilities: Office of Health Research physically located in the School of Public Health and Tropical Medicine;and Clinical Trials Cooperative located within Tulane Hospital. Both facilities have clinical research laboratories with a wide range of capabilities. The former also has ultrasound capabilities, a variety of equipment for vascular studies, EKG machines, and ability to perform iothalamate glomerular filtration testing. The goal is to facilitate and foster the translation of basic insights into clinical and population studies. This core will extend the existing synergies which have been developed in the first two phases of the COBRE. All of the Core personnel are experienced in clinical investigation and are knowledgeable about the ongoing research within each of the areas involved in the existing COBRE. Therefore the core will be well suited to encourage and promote new investigators into translational studies.
Clinical and translational research in hypertension and renal diseases is an appropriate extension of ongoing basic research at Tulane. These studies have significant opportunity to improve prevention, detection, and treatment of these widespread disorders.
|Rahman, Mahboob; Yang, Wei; Akkina, Sanjeev et al. (2014) Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study. Clin J Am Soc Nephrol 9:1190-8|
|Scialla, Julia J; Xie, Huiliang; Rahman, Mahboob et al. (2014) Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 25:349-60|
|Yoshida, Tadashi; Huq, Tashfin S; Delafontaine, Patrice (2014) Angiotensin type 2 receptor signaling in satellite cells potentiates skeletal muscle regeneration. J Biol Chem 289:26239-48|
|Miyata, Kayoko; Satou, Ryousuke; Inui, Daisuke et al. (2014) Renoprotective effects of direct renin inhibition in glomerulonephritis. Am J Med Sci 348:306-14|
|Miyata, Kayoko; Satou, Ryousuke; Shao, Weijian et al. (2014) ROCK/NF-?B axis-dependent augmentation of angiotensinogen by angiotensin II in primary-cultured preglomerular vascular smooth muscle cells. Am J Physiol Renal Physiol 306:F608-18|
|Gonzalez, Alexis A; Womack, Joel P; Liu, Liu et al. (2014) Angiotensin II increases the expression of (pro)renin receptor during low-salt conditions. Am J Med Sci 348:416-22|
|Hilliard, Sylvia A; Yao, Xiao; El-Dahr, Samir S (2014) Mdm2 is required for maintenance of the nephrogenic niche. Dev Biol 387:1-14|
|Blackstock, Christopher D; Higashi, Yusuke; Sukhanov, Sergiy et al. (2014) Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA. J Biol Chem 289:7264-74|
|Chirinos, Julio A; Khan, Abigail; Bansal, Nisha et al. (2014) Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study. Circ Heart Fail 7:709-16|
|Navar, L Gabriel (2014) Physiology: hemodynamics, endothelial function, renin-angiotensin-aldosterone system, sympathetic nervous system. J Am Soc Hypertens 8:519-24|
Showing the most recent 10 out of 29 publications